Elsevier

Metabolism

Volume 48, Issue 10, October 1999, Pages 1332-1335
Metabolism

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity

https://doi.org/10.1016/S0026-0495(99)90277-9Get rights and content

Abstract

Fat tissue is a significant source of endogenous tumor necrosis factor alpha (TNFα), the pluripotent cytokine that plays an important role as a mediator of the peripheral insulin resistance found in obesity. The majority of evidence for this role of TNFα is from studies in animal models of obesity. To explore further the role of TNFα in the pathogenesis of obesity-related insulin resistance in humans, we compared plasma levels of TNFα and the other main endocrine cytokine, interleukin-6 ([IL-6] both measured by enzyme-linked immunosorbent assay), in 26 obese women (body mass index [BMI] > 30 kg/m2) and 13 female controls (BMI < 26 kg/m2) without a history of recent or active infection. Glucose and insulin levels were measured at 0, 1, and 2 hours after a 75-g oral glucose load. There was no significant difference in plasma TNFα or IL-6 levels between obese and non-obese subjects overall (2.10 ± 0.19 v 1.65 ± 0.18 pg/mL and 2.06 ± 0.29 v 1.50 ± 0.17 pg/mL, respectively). However, TNFα levels were significantly elevated in obese subjects with a 2-hour glucose level more than 140 mg/dL (n = 8) compared with the other obese subjects (n = 18) and the non-obese controls (2.88 ± 0.46 v 1.75 ± 0.10 and 1.65 ± 0.18 pg/mL, respectively, P < .01). Furthermore, the TNFα level correlated significantly with the waist to hip ratio ([WHR] r = .53, P < .01) and fasting and post—oral glucose tolerance test (OGTT) insulin levels (r = .47, P < .02), but not with the BMI, and was higher in obese women with a WHR more than 0.90 (n = 14) in comparison to those with a WHR less than 0.90 (n = 12, 2.47 ± 0.29 v 1.66 ± 0.18 pg/mL, respectively, P < .03). The corresponding plasma leptin level was significantly higher in obese women versus the control group (41.6 ± 2.5 v 22.3 ± 2.9 ng/mL, P < .001) and was related to the BMI (r = .60, P < .01) but not to TNFα or the WHR. There were no significant differences in the corresponding IL-6 concentration between groups, and IL-6 did not correlate with TNFα, leptin, BMI, WHR, or insulin levels. In conclusion, circulating TNFα levels are higher in abdominal obesity compared with peripheral obesity, and may contribute to the insulin resistance that more commonly complicates the former pattern of fat distribution.

References (25)

  • LA Tartaglia et al.

    Two TNF receptors

    Immunol Today

    (1992)
  • WA Hsueh et al.

    Cardiovascular risk continuum: Implications of insulin resistance and diabetes

    Am J Med

    (1998)
  • S Akira et al.

    Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF)

    FASEB J

    (1990)
  • C Grunfeld et al.

    The metabolic effects of tumor necrosis factor and other cytokines

    Biotherapy

    (1991)
  • GS Hotamisligil et al.

    Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance

    Science

    (1993)
  • GS Hotamisligil et al.

    TNFα: A key component of obesity-diabetes link

    Diabetes

    (1994)
  • GS Hotamisligil et al.

    Increased adipose expression of tumor necrosis factor-a in human obesity and insulin resistance

    J Clin Invest

    (1995)
  • M Saghizadeh et al.

    The expression of TNFα by human muscle: Relationship to insulin resistance

    J Clin Invest

    (1996)
  • PA Kern et al.

    The expression of tumor necrosis factor in adipose tissue: Regulation by obesity, weight loss, and relationship to lipoprotein lipase

    J Clin Invest

    (1995)
  • GS Hotamisligil et al.

    Tumor necrosis factor a inhibits signalling from the insulin receptor

  • LS Liu et al.

    Tumor necrosis factor-a acutely inhibits insulin signalling in human adipocytes

    Diabetes

    (1998)
  • GS Hotamisligil et al.

    IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a- and obesity-induced insulin resistance

    Science

    (1996)
  • Cited by (0)

    View full text